InvestorsHub Logo

CT

Followers 3
Posts 148
Boards Moderated 0
Alias Born 07/08/2002

CT

Re: DewDiligence post# 14637

Monday, 10/05/2015 3:46:17 PM

Monday, October 05, 2015 3:46:17 PM

Post# of 20689
Does "interchangeable" convey a market advantage in the case where the price of MNTA's FoB is priced similarly to a non-interchangeable?

Is it the case where a doctor prescribes Humira and that gets auto switched to MNTA FoB because of PBM/insurance/other rules whereas the non-interchangeable has to be explicitly prescribed?